APA (7th ed.) Citation

Pensato, U., Baraldi, C., Favoni, V., Cainazzo, M. M., Torelli, P., Querzani, P., . . . Cevoli, S. (2022). Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache. Neurological Sciences, 43(2), 1273. https://doi.org/10.1007/s10072-021-05426-5

Chicago Style (17th ed.) Citation

Pensato, Umberto, et al. "Real-life Assessment of Erenumab in Refractory Chronic Migraine with Medication Overuse Headache." Neurological Sciences 43, no. 2 (2022): 1273. https://doi.org/10.1007/s10072-021-05426-5.

MLA (9th ed.) Citation

Pensato, Umberto, et al. "Real-life Assessment of Erenumab in Refractory Chronic Migraine with Medication Overuse Headache." Neurological Sciences, vol. 43, no. 2, 2022, p. 1273, https://doi.org/10.1007/s10072-021-05426-5.